Original Article
Subject Category: Cell Biology
Journal of Investigative Dermatology (2008) 128, 816–824; doi:10.1038/sj.jid.5701102; published online 18 October 2007
Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D3
Jürgen Schauber1,2, Yuko Oda3, Amanda S Büchau1, Qian-Chun Yun4, Andreas Steinmeyer5, Ulrich Zügel6, Daniel D Bikle3 and Richard L Gallo1
- 1Division of Dermatology, University of California, San Diego and VA San Diego Healthcare System, San Diego, California, USA
- 2Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany
- 3Department of Medicine, Endocrine Unit, Veterans Affairs Medical Centre, University of California, San Francisco, California, USA
- 4School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- 5Medicinal Chemistry, Bayer Schering Pharma AG, Berlin, Germany
- 6Therapeutic Research Group Inflammation & Immunology, Global Drug Discovery, Bayer Schering Pharma AG, Berlin, Germany
Correspondence: Dr Richard L. Gallo, 3350 La Jolla Village Drive, Mail Code 151, San Diego, California 92161, USA. E-mail: rgallo@ucsd.edu
Received 12 June 2007; Revised 30 July 2007; Accepted 13 August 2007; Published online 18 October 2007.
Abstract
Hormonally active vitamin D3—1,25-dihydroxyvitamin D3 (1,25D3)—acts as a signaling molecule in cutaneous immunity by increasing pattern recognition through Toll-like receptor-2 (TLR2), and increasing the expression and function of antimicrobial peptides. Here we show that the actions of 1,25D3 on keratinocyte innate immune responses are influenced by histone acetylation and require the steroid receptor coactivator 3 (SRC3), which mediates inherent histone acetyltransferase (HAT) activity. SRC3 was detected in the suprabasal and granular layer of the skin, similar to cathelicidin expression. HAT activity was important to keratinocyte cathelicidin expression as the combination of histone deacetylase inhibitors (HDACi) (butyrate or trichostatin A) and 1,25D3 increased cathelicidin and CD14 expression and enhanced the antimicrobial function of keratinocytes against Staphylococcus aureus. This treatment, or activation of TLR2, also directly increased acetylation of histone 4. Small interfering RNA silencing of the vitamin D receptor or SRC3 blocked the induction of cathelicidin and CD14 by 1,25D3. HDACi could not reverse this effect or influence cathelicidin in the absence of 1,25D3, suggesting that both are necessary for function. These studies demonstrate that the epigenetic control of gene transcription by histone acetylation is important for 1,25D3-regulated antimicrobial and TLR function of keratinocytes, essential elements of the innate immune response of the skin.
Abbreviations:
1,25D3, 1,25-dihydroxyvitamin D3; HAT, histone acetyltransferase; HDACi, histone deacetylase inhibitors; NHEK, normal human epidermal keratinocyte; SRC, steroid receptor coactivator; TLR, Toll-like receptor; TSA, trichostatin A; VDR, vitamin D receptor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Defending the epitheliumNature Medicine News and Views (01 Jun 2006)
Fighting infections with vitamin DNature Medicine News and Views (01 Apr 2006)
RESEARCH
Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D3Journal of Investigative Dermatology Original Article
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in KeratinocytesJournal of Investigative Dermatology Original Article
See all 52 matches for Research

